Fifteen patients with regional enteritis (14) or ulcerative colitis (one) who were refractory to medical management were treated by bowel rest and intravenous hyperalimentation (IVH). Nine received IVH as primary therapy and all had remissions. Four have done well for four months to three years. Four had recurrences and one died later. Six patients received IVH before planned operations for localized disease. Five had no recurrences for six months to three years and one did not tolerate IVH. The role of IVH for inflammatory bowel disease can be both in preparation for operation and as primary therapy for acute episodes. We reserve IVH as primary therapy for patients with previous resections or extensive disease. It has provided prolonged remissions in some and prevented further operations in most. However, the long-term course of the disease was not altered.
Vogel CM, Corwin TR, Baue AE. Intravenous Hyperalimentation: In the Treatment of Inflammatory Diseases of the Bowel. Arch Surg. 1974;108(4):460–467. doi:10.1001/archsurg.1974.01350280066012
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: